The purpose of the study is to assess the safety and efficacy of Arazlo Lotion (Tazarotene 0.045% Lotion) for treatment of postinflammatory erythema and postinflammatory hyperpigmentation in subjects with acne.

Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne

A Prospective, Single-center, Pilot Study to Evaluate the Efficacy, Safety, and Tolerability of Tazarotene 0.045% Lotion (Arazlo) for Treating Postinflammatory Erythema and Postinflammatory Hyperpigmentation in Subjects With Acne

Treatment Trials

Focus your search

Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne

Description

Conditions